MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LUCAS, M.
Right arrow Articles by BOCKAERT, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LUCAS, M.
Right arrow Articles by BOCKAERT, J.

Molecular Pharmacology, Vol 15, 588-597, Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics

In Vitro and In Vivo Kinetic Analysis of the Interaction of a Norbornyl Derivative of Propranolol with beta-Adrenergic Receptors of Brain and C6 Glioma Cells; an Irreversible or Slowly Reversible Ligand

MARGUERITE LUCAS 1, VINCENT HOMBURGER 1, ANNETTE DOLPHIN 1, and JOËL BOCKAERT 1

1 Laboratoire de Physiologie Cellulaire, Collège de France, 11, Place Marcelin Berthelot, 75231 PARIS CEDEX 05

When injected into rats (30 mg/kg, i.p.), a norbornyl derivative of propranolol, 1-(2-exobicyclo[2,2,1]Hept-2-ylphenox)-3-[(1-methyl-ethylamino]-2-propanol (FM 24) blocked by 85% the cerebral cortex beta-adrenergic receptors measured on membranes prepared five hours after the treatment. The preparation of membranes included extensive washing and a 75 min incubation period at 37°. Injection of propranolol at the same dose did not modify the number of beta-adrenergic receptors in these membranes. When membranes were prepared 11 hours after a single injection of FM 24, 50% of beta-adrenergic receptors were still blocked; more than 24 hours were necessary for complete recovery. A detailed analysis of the FM 24 interaction with beta-adrenergic receptors was performed on beta-adrenergic receptors of C6 glioma cells. FM 24 behaves as a competitive antagonist of the [3H]-dihydroalprenolol binding and of the isoproterenol sensitive adenylate cyclase (KI = 50 µM) when measured during a short period after starting the reaction. When measured after different incubation periods, FM 24 blocked the beta-adrenergic receptors in a mixed competitive and non-competitive manner. The non-competitive inhibition was time and concentration dependent. The time course of this non-competitive inhibition was delayed by the presence of the beta-adrenergic agonist isoproterenol. When membranes were washed, only the non-competitive inhibition of both [3H]-dihydroalprenolol binding and beta-adrenergic sensitive adenylate cyclase remained. It is proposed that the FM 24 formed a reversible complex with beta-adrenergic receptors which is slowly transformed to a more stable complex. An analysis of the dissociation of this more stable complex showed two components, one which dissociated within one hour and the other which did not dissociate even after 5 hours of incubation.

Note:
ACKNOWLEDGMENTS We are indebted to Drs. Uzan and Le Fur for donation of FM 24, and interesting discussion, and would like to acknowledge the excellent technical assistance of Michelle Perez and Mina Cherif.

Submitted on July 31, 1978
Accepted on November 27, 1978







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics